Biotech Breakthroughs

Results

56

1 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

56 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MDGL	US$553.48	4.2%	67.2%	US$12.8b	US$678.86	11.3	59.1%	n/a	Pharmaceuticals & Biotech
	SNDX	US$22.80	-0.4%	134.3%	US$2.0b	US$39.00	9.3	68.1%	n/a	Pharmaceuticals & Biotech
	ARDX	US$5.20	1.2%	17.6%	US$1.3b	US$16.30	3.0	55.9%	n/a	Pharmaceuticals & Biotech
	MRKR	US$1.31	-10.3%	-14.4%	US$21.8m	US$7.87	6.2	69.0%	n/a	Pharmaceuticals & Biotech
	ANAB	US$58.00	-16.9%	121.6%	US$1.7b	US$87.09	7.4	48.1%	38.8%	Pharmaceuticals & Biotech
	LCTX	US$1.16	-4.1%	22.8%	US$289.2m	US$5.50	19.6	72.2%	n/a	Pharmaceuticals & Biotech
	FRMM	US$5.68	-12.3%	-79.8%	US$75.0m	US$9.50	8.0	127.7%	n/a	Pharmaceuticals & Biotech
	ACHV	US$6.27	2.8%	135.7%	US$643.7m	US$13.80	60.3	64.3%	n/a	Pharmaceuticals & Biotech
	TNYA	US$0.82	-2.3%	-4.6%	US$177.3m	US$4.00	787.9	60.9%	n/a	Pharmaceuticals & Biotech
	NTLA	US$11.38	-12.6%	-9.9%	US$1.6b	US$26.17	24.0	67.9%	n/a	Pharmaceuticals & Biotech
	RNXT	US$0.87	-5.3%	-32.9%	US$39.0m	US$7.03	26.2	73.0%	n/a	Pharmaceuticals & Biotech
	CAPR	US$19.44	-5.7%	210.0%	US$1.1b	US$53.60	4.0	64.2%	n/a	Pharmaceuticals & Biotech
	ALDX	US$1.69	-12.4%	-68.6%	US$101.9m	US$7.17	2.4	66.9%	n/a	Pharmaceuticals & Biotech
	CTOR	US$0.69	-2.3%	-53.5%	US$64.1m	US$4.00	11.4	59.9%	n/a	Pharmaceuticals & Biotech
	LGVN	US$0.62	-1.4%	-63.0%	US$19.7m	US$7.15	16.2	55.5%	n/a	Pharmaceuticals & Biotech
	ACIU	US$2.20	-10.2%	5.8%	US$218.2m	US$8.55	47.6	54.4%	n/a	Pharmaceuticals & Biotech
	VRDN	US$18.03	-5.1%	7.4%	US$2.0b	US$36.13	28.1	60.9%	n/a	Pharmaceuticals & Biotech
	HUMA	US$0.66	-3.8%	-71.1%	US$179.2m	US$2.05	88.9	60.9%	n/a	Pharmaceuticals & Biotech
	CGON	US$71.85	-0.9%	167.1%	US$6.3b	US$90.29	1249.7	60.1%	n/a	Pharmaceuticals & Biotech
	ARQT	US$28.49	5.1%	98.7%	US$3.6b	US$34.63	8.6	48.1%	n/a	Pharmaceuticals & Biotech
	MNOV	US$1.35	-0.7%	7.1%	US$66.4m	US$9.00	111.4	66.7%	n/a	Pharmaceuticals & Biotech
	LRMR	US$3.70	-0.7%	13.5%	US$386.2m	US$14.40	2.4	52.5%	n/a	Pharmaceuticals & Biotech
	VERA	US$38.50	-7.2%	68.9%	US$2.8b	US$81.79	5.5	63.8%	n/a	Pharmaceuticals & Biotech
	NAMS	US$31.68	-4.8%	40.4%	US$3.7b	US$49.86	164.1	64.3%	n/a	Pharmaceuticals & Biotech

Page 1 of 2